 Connection
Edward Ashwood to United States
This is a "connection" page, showing publications Edward Ashwood has written about United States.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.132 |
|
|
|
-
Lo SF, Doumas BT, Ashwood ER. Performance of bilirubin determinations in US laboratories--revisited. Clin Chem. 2004 Jan; 50(1):190-4.
Score: 0.018
-
Lepage N, Wyatt P, Ashwood ER, Best RG, Long T, Palomaki GE. Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020. J Med Screen. 2021 12; 28(4):405-410.
Score: 0.015
-
Palomaki GE, Wyatt P, Best RG, Lepage N, Ashwood ER, Souers RJ, Thorson JA. Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784.
Score: 0.014
-
Ashwood ER. Acute coronary syndromes: from bench to bedside--the Twenty-first annual Arnold O. Beckman Conference in Clinical Chemistry. Clin Chem. 1998 Aug; 44(8 Pt 2):1795-7.
Score: 0.013
-
Walker BS, Nelson RE, Jackson BR, Grenache DG, Ashwood ER, Schmidt RL. A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS One. 2015; 10(7):e0131402.
Score: 0.010
-
Palomaki GE, Ashwood ER, Best RG, Lambert-Messerlian G, Knight GJ. Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States? Genet Med. 2015 Nov; 17(11):897-900.
Score: 0.010
-
Balis UJ, Aller RD, Ashwood ER. Informatics training in U.S. pathology residency programs. Results of a survey. Am J Clin Pathol. 1993 Oct; 100(4 Suppl 1):S44-7.
Score: 0.009
-
Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013 Jul; 137(7):921-6.
Score: 0.009
-
Scott MG, Ashwood ER, Annesley TM, Leonard DG, Burgess MC. FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories? Clin Chem. 2013 Jul; 59(7):1017-22.
Score: 0.009
-
Ashwood ER, Labart PL. Laboratory information system test environment: validate upgrades, prevent disasters, and assist training. Clin Lab Manage Rev. 1992 Jan-Feb; 6(1):66-8, 70-1.
Score: 0.008
-
Talbert ML, Ashwood ER, Brownlee NA, Clark JR, Horowitz RE, Lepoff RB, Neumann A, Otis CN, Powell SZ, Sodeman TM. Resident preparation for practice: a white paper from the College of American Pathologists and Association of Pathology Chairs. Arch Pathol Lab Med. 2009 Jul; 133(7):1139-47.
Score: 0.007
-
Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Ehlers GW, Hassemer D, Lo SF, Seccombe D, Siekmann L, Thienpont LM, Toth A. State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. Arch Pathol Lab Med. 2008 May; 132(5):838-46.
Score: 0.006
-
Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch Pathol Lab Med. 2005 Mar; 129(3):297-304.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|